MML Investors Services
ARRY

MML Investors Services’s Array Biopharma Inc ARRY Stock Holding History

MML Investors Services’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,899
Closed -$366K – 1656
2019
Q2 		$366K Sell
7,899
-699
-8% -$19.6K 0.01% 1182
2019
Q1 		$210K Buy
+8,598
New +$179K ﹤0.01% 1464

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

MML Investors Services's ARRY Position: Q3 2019 in Review

MML Investors Services sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 7,899 shares — an estimated $366K sold.

MML Investors Services first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $366K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • MML Investors Services reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • MML Investors Services sold 7,899 Array Biopharma Inc shares in Q3 2019, an estimated $366K.
  • MML Investors Services first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
  • MML Investors Services's Array Biopharma Inc position peaked at $366K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on MML Investors Services's 13F filing for Q3 2019, filed 14 Nov 2019.